<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35576897</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>08</Day></DateCompleted><DateRevised><Year>2022</Year><Month>09</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1423-0208</ISSN><JournalIssue CitedMedium="Internet"><Volume>56</Volume><Issue>4</Issue><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Neuroepidemiology</Title><ISOAbbreviation>Neuroepidemiology</ISOAbbreviation></Journal><ArticleTitle>Genetic Epidemiology of Amyotrophic Lateral Sclerosis in Norway: A 2-Year Population-Based Study.</ArticleTitle><Pagination><StartPage>271</StartPage><EndPage>282</EndPage><MedlinePgn>271-282</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1159/000525091</ELocationID><Abstract><AbstractText Label="BACKGROUND">Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that affects motor neurons. In Europe, disease-causing genetic variants have been identified in 40-70% of familial ALS patients and approximately 5% of sporadic ALS patients. In Norway, the contribution of genetic variants to ALS has not yet been studied. In light of the potential development of personalized medicine, knowledge of the genetic causes of ALS in a population is becoming increasingly important. The present study provides clinical and genetic data on familial and sporadic ALS patients in a Norwegian population-based cohort.</AbstractText><AbstractText Label="METHODS">Blood samples and clinical information from ALS patients were obtained at all 17 neurological departments throughout Norway during a 2-year period. Genetic analysis of the samples involved expansion analysis of C9orf72 and exome sequencing targeting 30 known ALS-linked genes. The variants were classified using genotype-phenotype correlations and bioinformatics tools.</AbstractText><AbstractText Label="RESULTS">A total of 279 ALS patients were included in the study. Of these, 11.5% had one or several family members affected by ALS, whereas 88.5% had no known family history of ALS. A genetic cause of ALS was identified in 31 individuals (11.1%), among which 18 (58.1%) were familial and 13 (41.9%) were sporadic. The most common genetic cause was the C9orf72 expansion (6.8%), which was identified in 8 familial and 11 sporadic ALS patients. Pathogenic or likely pathogenic variants of SOD1 and TBK1 were identified in 10 familial and 2 sporadic cases. C9orf72 expansions dominated in patients from the Northern and Central regions, whereas SOD1 variants dominated in patients from the South-Eastern region.</AbstractText><AbstractText Label="CONCLUSION">In the present study, we identified several pathogenic gene variants in both familial and sporadic ALS patients. Restricting genetic analysis to only familial cases would miss more than 40 percent of those with a disease-causing genetic variant, indicating the need for genetic analysis in sporadic cases as well.</AbstractText><CopyrightInformation>&#xa9; 2022 The Author(s). Published by S. Karger AG, Basel.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Olsen</LastName><ForeName>Cathrine Goberg</ForeName><Initials>CG</Initials><AffiliationInfo><Affiliation>Department of Medical Genetics, Telemark Hospital Trust, Skien, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Clinical Medicine, University of Oslo, Nordbyhagen, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Busk</LastName><ForeName>&#xd8;yvind L&#xf8;vold</ForeName><Initials>&#xd8;L</Initials><AffiliationInfo><Affiliation>Department of Medical Genetics, Telemark Hospital Trust, Skien, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aanjesen</LastName><ForeName>Tori Navestad</ForeName><Initials>TN</Initials><AffiliationInfo><Affiliation>Department of Neurology, Akershus University Hospital, L&#xf8;renskog, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alstadhaug</LastName><ForeName>Karl Bj&#xf8;rnar</ForeName><Initials>KB</Initials><AffiliationInfo><Affiliation>Department of Neurology, Nordland Hospital Trust, Bod&#xf8;, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bj&#xf8;rn&#xe5;</LastName><ForeName>Ingrid Kristine</ForeName><Initials>IK</Initials><AffiliationInfo><Affiliation>Department of Neurology, Vestre Viken Hospital Trust, Drammen, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Braathen</LastName><ForeName>Geir Julius</ForeName><Initials>GJ</Initials><AffiliationInfo><Affiliation>Department of Medical Genetics, Telemark Hospital Trust, Skien, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Breivik</LastName><ForeName>Kristin Lif</ForeName><Initials>KL</Initials><AffiliationInfo><Affiliation>Department of Neurology, F&#xf8;rde Hospital Trust, F&#xf8;rde, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Demic</LastName><ForeName>Natasha</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Neurology, Vestfold Hospital Trust, T&#xf8;nsberg, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Flemmen</LastName><ForeName>Heidi &#xd8;yen</ForeName><Initials>H&#xd8;</Initials><AffiliationInfo><Affiliation>Department of Neurology, Telemark Hospital Trust, Skien, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hallerstig</LastName><ForeName>Erika</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Neurology, &#xd8;stfold Hospital Trust, Gr&#xe5;lum, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>HogenEsch</LastName><ForeName>Ineke</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Neurology, Fonna Hospital Trust, Haugesund, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holla</LastName><ForeName>&#xd8;ystein Lunde</ForeName><Initials>&#xd8;L</Initials><AffiliationInfo><Affiliation>Department of Medical Genetics, Telemark Hospital Trust, Skien, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>J&#xf8;ntvedt</LastName><ForeName>Anne Berit</ForeName><Initials>AB</Initials><AffiliationInfo><Affiliation>Department of Neurology, Telemark Hospital Trust, Skien, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kampman</LastName><ForeName>Margitta T</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Department of Neurology, University Hospital of North Norway, Troms&#xf8;, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kleveland</LastName><ForeName>Grethe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Neurology, Innlandet Hospital Trust, Lillehammer, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kvernmo</LastName><ForeName>Helene Ballo</ForeName><Initials>HB</Initials><AffiliationInfo><Affiliation>Department of Neurology and Clinical Neurophysiology, St.Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuromedicine and Movement Science, Norwegian University of Science and Technology, Trondheim, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lj&#xf8;stad</LastName><ForeName>Unn</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Department of Neurology, S&#xf8;rlandet Hospital Trust, Kristiansand, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Medicine, University of Bergen, Bergen, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maniaol</LastName><ForeName>Angelina</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, Oslo University Hospital, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morsund</LastName><ForeName>&#xc5;se Hagen</ForeName><Initials>&#xc5;H</Initials><AffiliationInfo><Affiliation>Department of Neurology, M&#xf8;re og Romsdal Hospital Trust, Molde, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakken</LastName><ForeName>Ola</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Neurology, Akershus University Hospital, L&#xf8;renskog, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Novy</LastName><ForeName>Camilla</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Medical Genetics, Telemark Hospital Trust, Skien, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Clinical Medicine, University of Oslo, Nordbyhagen, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rekand</LastName><ForeName>Tiina</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neurology, Haukeland University Hospital, Bergen, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schl&#xfc;ter</LastName><ForeName>Katrin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, Stavanger University Hospital, Stavanger, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sch&#xfc;ler</LastName><ForeName>Stephan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Nord-Tr&#xf8;ndelag Hospital Trust, Namsos, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tveten</LastName><ForeName>Kristian</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Medical Genetics, Telemark Hospital Trust, Skien, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tysnes</LastName><ForeName>Ole-Bj&#xf8;rn</ForeName><Initials>OB</Initials><AffiliationInfo><Affiliation>Department of Neurology, Haukeland University Hospital, Bergen, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holm&#xf8;y</LastName><ForeName>Trygve</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Institute of Clinical Medicine, University of Oslo, Nordbyhagen, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Akershus University Hospital, L&#xf8;renskog, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>H&#xf8;yer</LastName><ForeName>Helle</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Medical Genetics, Telemark Hospital Trust, Skien, Norway.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>05</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Neuroepidemiology</MedlineTA><NlmUniqueID>8218700</NlmUniqueID><ISSNLinking>0251-5350</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C531617">Amyotrophic lateral sclerosis 1</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017720" MajorTopicYN="N">Molecular Epidemiology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Epidemiology</Keyword><Keyword MajorTopicYN="N">Genetics</Keyword><Keyword MajorTopicYN="N">Norway</Keyword><Keyword MajorTopicYN="N">Population-based study</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>5</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>5</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>5</Month><Day>16</Day><Hour>18</Hour><Minute>32</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35576897</ArticleId><ArticleId IdType="doi">10.1159/000525091</ArticleId><ArticleId IdType="pii">000525091</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>